Comerica Securities’s Guardant Health GH Stock Holding History

Comerica Securities’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11	Closed	-$299	–	840
2022 Q4	$299	Buy	+11	New	+$503	﹤0.01%	1461

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Comerica Securities's GH Position: Q1 2023 in Review

Comerica Securities sold out of Guardant Health (GH) in Q1 2023, closing a stake of 11 shares — an estimated $299 sold.

Comerica Securities first reported a position in GH in Q4 2022 and held it in 1 quarter. The position peaked at $299 in Q4 2022. 278 funds tracked by Wall St. Rank hold GH as of Q1 2023.

Comerica Securities reported no remaining Guardant Health position as of Q1 2023 after selling out during the quarter.
Comerica Securities sold 11 Guardant Health shares in Q1 2023, an estimated $299.
Comerica Securities first reported a position in Guardant Health in Q4 2022 and held it in 1 quarter.
Comerica Securities's Guardant Health position peaked at $299 in Q4 2022.
278 funds tracked by Wall St. Rank held Guardant Health as of Q1 2023.

Based on Comerica Securities's 13F filing for Q1 2023, filed 27 Apr 2023.